Stock analysis, AI verdict, fundamentals & technical signals
Rating: SELL
Price: $38.18 Analyst target: $36.50 Upside: -4.40%
Efoora Inc. develops rapid diagnostic tests and biosensors for testing and diagnosing diseases including HIV, Hepatitis B and C, malaria, pregnancy, bovine spongiform encephalopathy (BSE), and chronic wasting disease (CWD). The company is headquartered in Buffalo Grove, Illinois.
See the full interactive analysis & chart →Informational only — not investment advice.